Shanghai Bao Pharmaceutical Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals: Major
  • ISIN: CNE100007B92
HKD
18.04
0.21 (1.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals: Major

stock-summary
Market cap

HKD 2,884 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.64

stock-summary
Return on Equity

-19.17%

stock-summary
Price to Book

1.63

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-80.07%
0%
-80.07%
6 Months
-81.19%
0%
-81.19%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Shanghai Bao Pharmaceutical Co. Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
163.80%
EBIT Growth (5y)
-53.92%
EBIT to Interest (avg)
-59.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
3.35
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.57
EV to EBIT
-4.81
EV to EBITDA
-5.45
EV to Capital Employed
2.56
EV to Sales
30.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-53.30%
ROE (Latest)
-19.17%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bullish
Bollinger Bands
Mildly Bearish
KST
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Shanghai Bao Pharmaceutical Co. Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 695.52% vs -12.99% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -8.50% vs -122.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.30",
          "val2": "6.70",
          "chgp": "695.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-302.10",
          "val2": "-356.80",
          "chgp": "15.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.50",
          "val2": "4.90",
          "chgp": "32.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-88.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-428.70",
          "val2": "-395.10",
          "chgp": "-8.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,423.00%",
          "val2": "-58,644.60%",
          "chgp": "5,222.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
53.30
6.70
695.52%
Operating Profit (PBDIT) excl Other Income
-302.10
-356.80
15.33%
Interest
6.50
4.90
32.65%
Exceptional Items
-88.90
0.00
Consolidate Net Profit
-428.70
-395.10
-8.50%
Operating Profit Margin (Excl OI)
-6,423.00%
-58,644.60%
5,222.16%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 695.52% vs -12.99% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -8.50% vs -122.97% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details